Invention Grant
- Patent Title: Aurora kinase inhibitors for inhibiting mitotic progression
-
Application No.: US17099266Application Date: 2020-11-16
-
Publication No.: US11958855B2Publication Date: 2024-04-16
- Inventor: Christopher F. Claiborne , Todd B. Sells , Stephen G. Stroud
- Applicant: Millennium Pharmaceuticals, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Millennium Pharmaceuticals, Inc.
- Current Assignee: Millennium Pharmaceuticals, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Jones Day
- The original application number of the division: US15996166 2018.06.01
- Main IPC: A61P35/00
- IPC: A61P35/00 ; A61K31/55 ; C07D487/04
Abstract:
The present invention relates to compounds and methods for the treatment of cancer. In particular, the invention provides potent inhibitors of Aurora A kinase, pharmaceutical compositions comprising the compounds, and methods of using the compounds for the treatment of cancer.
Public/Granted literature
- US20210214361A1 AURORA KINASE INHIBITORS FOR INHIBITING MITOTIC PROGRESSION Public/Granted day:2021-07-15
Information query
IPC分类:
| A | 人类生活必需 |
| A61 | 医学或兽医学；卫生学 |
| A61P | 化合物或药物制剂的特定治疗活性 |
| A61P35/00 | 抗肿瘤药 |
